We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTCS icon
4451
BTCS Inc
BTCS
$53.3M
$6.01K ﹤0.01%
3,417
-3,020
-47% -$4.96K
CTBI icon
4452
Community Trust Bancorp
CTBI
$1.44B
$6.01K ﹤0.01%
141
-3,639
-96% -$148K
EP icon
4453
Empire Petroleum
EP
$111M
$6K ﹤0.01%
1,174
-187
-14% -$1.2K
IRIX icon
4454
IRIDEX
IRIX
$14.3M
$6K ﹤0.01%
2,012
+1,123
+126% +$3.04K
AUUD
4455
Auddia
AUUD
$5.47M
$5.99K ﹤0.01%
+24
New +$14.1K
IKT icon
4456
Inhibikase Therapeutics
IKT
$378M
$5.99K ﹤0.01%
2,771
-3,148
-53% -$6.95K
ONCT
4457
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.98K ﹤0.01%
664
+416
+168% +$3.66K
CSQ icon
4458
Calamos Strategic Total Return Fund
CSQ
$3.37B
$5.96K ﹤0.01%
+364
New +$5.69K
FRD icon
4459
Friedman Industries
FRD
$319M
$5.96K ﹤0.01%
318
– –
CURV icon
4460
Torrid Holdings
CURV
$230M
$5.96K ﹤0.01%
1,221
-1,536
-56% -$7.58K
EBF icon
4461
Ennis
EBF
$559M
$5.95K ﹤0.01%
290
-5,032
-95% -$103K
NRC icon
4462
NRC Health Common Stock
NRC
$471M
$5.94K ﹤0.01%
150
-4,141
-97% -$164K
AVIR icon
4463
Atea Pharmaceuticals
AVIR
$406M
$5.94K ﹤0.01%
1,470
-28,870
-95% -$113K
YHGJ icon
4464
Yunhong Green CTI Ltd
YHGJ
$8.87M
$5.94K ﹤0.01%
374
+284
+316% +$4.68K
BWEN icon
4465
Broadwind
BWEN
$125M
$5.93K ﹤0.01%
2,490
-61
-2% -$150
VTNR
4466
DELISTED
Vertex Energy, Inc
VTNR
$5.92K ﹤0.01%
4,228
-3,139
-43% -$5.01K
MITK icon
4467
Mitek Systems
MITK
$853M
$5.91K ﹤0.01%
419
-9,493
-96% -$116K
CISO
4468
CISO Global
CISO
$12.2M
$5.9K ﹤0.01%
4,839
+1,055
+28% +$1.6K
MURA
4469
DELISTED
Mural Oncology
MURA
$5.9K ﹤0.01%
1,207
-1,319
-52% -$6.4K
SYPR icon
4470
Sypris Solutions
SYPR
$49.5M
$5.9K ﹤0.01%
3,712
-576
-13% -$1.11K
KZR
4471
DELISTED
Kezar Life Sciences
KZR
$5.89K ﹤0.01%
653
-495
-43% -$4.51K
TUP
4472
DELISTED
Tupperware Brands Corporation
TUP
$5.89K ﹤0.01%
4,395
+2,798
+175% +$4.46K
BME icon
4473
BlackRock Health Sciences Trust
BME
$576M
$5.88K ﹤0.01%
+142
New +$5.95K
AFARU
4474
DELISTED
Aura FAT Projects Acquisition Corp Unit
AFARU
$5.88K ﹤0.01%
519
– –
BMO icon
4475
Bank of Montreal
BMO
$129B
$5.86K ﹤0.01%
60
-6,002
-99% -$567K
177 178
179
180 181

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.